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Abstract
We present a case of emergency mitral valve replacement with the first — to the best of our knowledge — use of Melody 
balloon expandable stented bioprosthesis in a 2-years-old patient with acute endocarditis, subsequent mitral (bicuspid) 
valve incompetence after aggressive infective destruction, with the symptoms of critical multiorgan failure.
The patient with a history of rapid deterioration after 2-weeks-long septicemia in the course of acute endocarditis was 
operated for life-saving indications. Melody valve was expanded over 16 mm TyShak balloon and implanted into a mitral 
position (Melody-MVR) with good result.
Based on actual knowledge concerning heart valves reconstructions and institutional experience we conclude that in-
fected mitral valve in children should be primary repaired, nevertheless Melody valve could be reasonable considered 
as a mitral prosthesis in patients with non-reparable conditions.
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Introduction
Despite a great progress in medical technologies there is 
no ‘ideal’ heart valve prosthesis that could be superior to 
patient’s own natural valve. The issue is twice as important 
in pediatric population because of small dimensions of the 
heart itself, and expected life-long growth of the patient. 
‘Graft overgrowth’ phenomenon is observed after almost 
every reconstructive procedure performed in small children, 
thus the risk of necessary reoperation is clearly defined in 
patients who underwent surgical correction of congenital 
heart defects at the age of first 6–12 months.
Current knowledge concerning heart valves reconstruc-
tions as well as personal experience naturally indicates 
a primary repair of every defected, damaged or insuffi-
cient valve in affected children [1]. The real hindrances 
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for modern pediatric cardiac surgery are ‘non-reparable’ 
heart valves with critical hemodynamics. Limited amount of 
prostheses designed for valve replacement in children, par-
ticularly for very small annular sizes less than 15–16 mm, 
and the need for individually-designed surgery makes the 
procedures twice as complicated.
Our interest of expandable valves comes from insti-
tutional experience with pulmonary implantations as well 
as literature data regarding a bovine jugular vein graft 
(Medtronic Melody valve) used for mitral replacement 
(MVR) in children. In spite of the fact that mitral Melody 
replacement procedures (Melody-MVR) are still reported 
casually, the authors consecutively show reliable tech-
niques and promising short-term results [2]. The main 
arguments to reach for Melody-MVR in selected patients 
were previously well defined advantages of Melody valve 
implanted in pulmonary position: perfect hemodynamics, 
favorable effective orifice area (EOA) index, low transan-
nular gradient and an unique potential for percutaneous 
transcatheter balloon dilation of expandable stented valve 
following the growth of the child [3, 4].
We present our initial considerations after emergency 
MVR with the first — to the best of our knowledge — use of 
Melody balloon expandable stented bioprosthesis (Melo-
dy-MVR) in pediatric patient suffering from aggressive acute 
endocarditis (AE), subsequent mitral valve incompetence 
and infective destruction of the both leaflets, with the 
symptoms of critical multiorgan failure.
Case report
Clinical report
The 2-years-old girl 12 kg body weight was referred for 
urgent-emergency surgical mitral repair, or mitral valve 
replacement procedure for life-saving indications after two 
weeks of antibiotic therapy in the course of septicemia 
due to acute endocarditis. The child demonstrated the 
progression of congestive heart failure because of massive 
mitral valve insufficiency (MVI), left ventricular (LV) failure 
and acute pulmonary edema, with artificial ventilation, 
inotropic support and intense stimulation of diuresis. The 
symptoms of renal and liver dysfunction with ascites, cen-
tral and peripheral edema were evident, while her circula-
tory de-compensation led to general deterioration despite 
advanced conventional intensive therapy. The diagnostics 
was based on transthoracic echocardiography (TTE) that 
showed massive MVI with fixed vegetations over posterior 
and anterior leaflets, with disrupted chordae. Additionally 
an infiltration over the left atrial posterior wall was seen 
(Figure 1).
Surgical technique
Medtronic Melody TPV 22 valve needed to be prepared 
before the beginning of the operation. To enable surgical 
implantation of the expandable valve the sewing cuff was 
added externally to the stent, in the middle of its longitu-
dinal diameter. We performed a cuff on the fully expanded 
valve washed consecutively for 9 minutes. Afterwards 
a 3-mm stripe of incised ePTFE (polytetrafluoroetylene) was 
cut, and secured to the stent using interrupted, superficial 
sutures. It’s very important to perform a shallow bites 
limited to anchor metal elements only, with a great care to 
avoid any disruption of the valve inserted in the stent. The 
collar was regularly incised every 6–8 mm on it is entire 
length to facilitate further balloon expansion, following 
the growth of the patient. After meticulous analysis of LV 
echocardiography diameters (the distance between the 
posterior wall and left ventricle outflow tract [LVOT] area) 
the excision of apical part of the valve adjacent to LVOT 
was necessary (Figure 2). The excised conduit material 
was secured to the remaining intact stent with meticulous 
single monofilament sutures, to save the valve structure 
and its function after implantation. The margin opposite 
Figure 1. Diagnostic transthoracic echocardiography (TTE) showed 
massive mitral valve insufficiency (MVI) with fixed vegetations over 
posterior and anterior leaflets and disrupted chordae
Figure 2. With the fully expanded valve a 3-mm stripe of incised 
ePTFE (polytetrafluoroetylene) was secured to the stent using in-
terrupted superficial sutures. The ventricular part of the stent was 
excised to prevent left ventricular outflow tract obstruction (LVOTO)
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to excised segments was marked with a single marking 
suture to facilitate proper orientation of the valve, and 
fixation to the posterior wall, or posterior papillary muscle, 
as recommended.
The procedure was performed with extracorporeal 
circulation (ECC), mild hypothermia, cardiac arrest and 
MV transseptal approach. After identification of AE vege-
tations on the both MV leaflets, despite gentle dissection, 
the leaflets appeared completely damaged, with disrupted 
chordae. Finally only a small rim of leaflets was left intact 
close to the annulus to facilitate implantation and prevent 
injury to conduction system and circumflex coronary artery. 
The head of posterior papillary muscle was indicated as 
a target for posterior fixation of the valvular stent. The 
annulus after leaflets resection was additionally sized with 
Hegar dilators (14–16–18 mm) to match the size of the 
balloon for final valve expansion.
The Melody valve was gently compressed and crimped 
by the surgeon over 5-ml syringe to enable the insertion 
through the mitral annulus. To provide a stable position 
and prevent tilting of the Melody valve into the LVOT during 
systole causing left ventricular outflow tract obstruction 
(LVOTO)-similar to systolic anterior motion phenomenon 
(SAM), the ventricular aspect of Melody stent was fixed to 
the incised head of posterior papillary muscle with a sin-
gle pledgeted monofilament suture. The suture tying was 
hampered because of registered approach and the stent in 
place, thus the knots were every time secured with delicate 
instruments. Additionally posterior-fixing suture was passed 
through ePTFE valvular ring, and tied after valve fixation. 
Afterwards the sewing ePTFE ring of the valve was sutured 
to prepared mitral annulus with the use of 3 semi-continu-
ous 5.0 monofilament circumferential sutures. The sutures 
were tightened and tied just after the balloon dilation of 
the stented valve.
Final dilation was performed with 16 mm/4 cm long 
TyShak balloon. The size of the balloon was planned follow-
ing preoperative measurements of the annulus with echo-
cardiography. The size was matched to intraoperative sizing 
with Hegars after excision of the valve on flaccid heart. The 
balloon catheter over soft “J” guidewire was carefully inser-
ted through the central lumen of the valve after removing 
of the syringe. Three consecutive inflations to 4 atm were 
done and the Melody was carefully inspected to ensure that 
the stent was regularly dilated. During the last dilation, the 
balloon was maintained at 4 atm pressure to tighten, and 
tie 3 circumferential semi-continuous sutures. The valve 
was meticulously inspected to ensure free mobility of all 
3 leaflets. LA vent was passed through the valve to ensure 
de-airing of LV with saline filling, and minimized ventricular 
compression to avoid any risk of deformation of the stent.
The atrial side of the stent was flared on its entire cir-
cumference to limit the protrusion of the valve into LA body 
(Figure 3). The atrial septum was closed with a calibrated 
foramen ovale-like ePTFE patch. The hole of the patch was 
faced with the inflow part of the Melody stent to enable 
future re-dilation of the valve. After subsequent deairing of 
the heart, and removing of the cross-clamp, sinus rhythm 
recovery with no signs of ischemia or local contractility 
problems was noticed. The ECC was terminated with an 
average inotropic support. Intraoperative epicardial echo-
cardiography (EE) confirmed good Melody function without 
any signs of LVOTO.
Postoperative care
The anticoagulation was started with intravenous heparin 
until oral aspirin was initiated, and chronically continued 
[5]. Antibiotic administration was continued due to thera-
peutic European Society of Cardiology (ESC) guidelines for 
bacterial endocarditis surgical treatment [6]. Further TTE 
controls confirmed good Melody valve function in mitral 
position (Figure 4). The girl was discharged home with 
negative blood cultures and inflammatory parameters; 
her intensive postoperative rehabilitation was continued.
Discussion
Valvular dysfunctions, stenosis as well as insufficiency, 
remain a challenge for professionals engaged in pediatric 
structural heart diseases, congenital and acquired. There is 
no doubt that heart valve repair is superior to replacement 
with any prosthesis, especially in subgroup of patients with 
expected long-life survival, growth potential and contrain-
dications to chronic anticoagulation [7].
There is growing list of promising reports of successful 
Melody-MVR procedures in children with congenital mitral 
valve defects. Despite still hardly mid-term follow up there 
are some significant arguments for utility of stented ex-
Figure 3. Postoperative chest X-ray with Melody stented valve: note 
the excision of ventricular part and flaring of the atrial segment
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appear superior over any other total artificial valve in septic 
surrounding. The vegetations and all infected tissues were 
carefully excised before the implantation; nevertheless there 
is still a hazard of Melody prosthesis local infection despite 
a vast spectrum of antibiotics. Expandable prosthesis im-
planted in presented technique enable better adjustment of 
valvular stent to native annulus without the need of extraor-
dinary tricks, like described for supraannular implantation of 
mechanical valve. The semi-continuous sutures implantation 
technique comes from personal experience with classic 
mitral replacements and was preferred by the operator.
The reports of Melody-MVR confirm good function at 
short-term follow-up, although there is not- up to the launch 
of the manuscript, known report of Melody valve implanted 
in mitral position in AE in a child. The risk of endocarditis 
on implanted Melody was reported and analyzed over 
prostheses implanted in RVOT, and several in-vitro studies 
[8, 9]. The risk of infection and damage of the Melody valve 
exposed for bacterial infection is similar to other biological 
valves, and implanted homografts [10].
All reported Melody-MVRs in children were carefully 
controlled because of perivalvular leaks, dysfunction of 
the device, or LVOTO. These unfavorable complications 
might require percutaneous intervention, reoperation, or 
replacement of implanted prosthesis. Other complications 
including LVOTO were reported in 10% of patients [4, 10].
 
 
Balloon expansion of the valve at up to 4 years following 
implantation has been reported for preserving valvular 
competence, and reduce gradient. There was no need 
for reoperation caused by Melody dysfunction or its local 
infection in mitral position. Perivalvular leaks or Melody-re-
lated LVOTO were casually reported, with a potential for 
transcatheter interventions [3].
Conclusions
The implantation of Melody valve in mitral position (Melody- 
-MVR) appeared safe and effective treatment for a child 
with non-reparable rapid acute endocarditis. The progress 
in the development of diminished devices designed for 
implantations into atrioventricular positions in children 
remains reasonable.
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pandable bioprostheses for mitral replacement in small 
children. Although the design of the device made it adjusted 
for implantation into the right ventricular outflow tract, its 
characteristics makes possible ‘hand-made’ modification 
of the prosthesis for alternative implantation into the mitral 
position.
The length of the Melody valve (usually 23–25 mm 
when expanded) predisposes the protrusion into the LV 
cavity, with the risk of LVOTO in smaller patients. There was 
a lack of a professionally-designed sewing cuff to implant 
the Melody device to the atrioventricular valve annulus. 
The modification of the valve stent with additionally sewed 
cuff, resection of its apical segments and flaring of the 
inflow part were necessary. These maneuvers facilitated 
atypical implantation, provided proper position in mitral 
annulus, and prevented from LVOTO [4]. The preparation 
of Melody valve was performed before the initiation of the 
procedure to limit the duration of cross-clamp and CPB, 
as recommended. In a case of unexpected difficulties or 
intraoperative change of the strategy, when the implan-
tation appears impossible — the Melody prosthesis is 
naturally lost.
Surgery in pediatric patients with AE is rare; thus, there 
is still limited number of available articles concerning mitral 
valve repairs, or replacement in small children suffering 
from AE. The decision to use Melody valve in acute endo-
carditis was made without any previous comparable data, 
or available recommendations. We strongly believed that 
biological stented expandable bioprosthesis could definitely 
Figure 4. Control transthoracic echocardiography (TTE) examina-
tion performed before the discharge showed good Melody function 
in mitral position
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Streszczenie
Przedstawiono opis pierwszej implantacji zastawki Melody w pozycję mitralną u 2-letniej dziewczynki z nienaprawialnym 
uszkodzeniem zastawki mitralnej w przebiegu infekcyjnego zapalenia wsierdzia. 
Dziewczynkę przyjęto w stanie krytycznym z niewydolnością wielonarządową; u dziecka doszło do nagłego pogorszenia 
stanu ogólnego po 2 tygodniach od rozpoznania bakteriemii w przebiegu infekcyjnego zapalenia wsierdzia. Z powodu 
gwałtownie narastających objawów niewydolności serca wszczepiono zastawkę Melody w miejsce całkowicie uszkodzo-
nej przez wegetacje bakteryjne zastawki mitralnej. Uzyskano dobrą funkcję zastawki Melody w pozycji mitralnej oraz 
stabilizację stanu dziecka.
W przebiegu zakażeń zastawki mitralnej postępowaniem z wyboru jest plastyka zastawki, jednak w przypadku nienapra-
wialnego uszkodzenia zastawki można rozważyć wszczepienie zastawki Melody w pozycję mitralną.
Słowa kluczowe: Melody, zastawka mitralna, infekcyjne zapalenie wsierdzia, kardiochirurgia dziecięca
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